Ambience Taps Valli for New CRO/CVO Role, Bets on AI Value
- 15 years of experience: Mike Valli, the newly appointed CRO/CVO, brings over 15 years of industry experience, including leadership roles at symplr and Optum.
- 100+ specialties: Ambience's AI platform automates clinical documentation across more than 100 medical specialties.
- Top-tier investors: The company is backed by investors including Oak HC/FT, Andreessen Horowitz (a16z), and the OpenAI Startup Fund.
Experts would likely conclude that Ambience Healthcare's strategic executive hires and focus on measurable AI value signal a critical shift toward operational, financial, and clinical outcomes in healthcare technology.
Ambience Healthcare Signals New Era of AI Value with Executive Hires
SAN FRANCISCO, CA – February 09, 2026 – Ambience Healthcare, a prominent AI platform for clinical workflows, has announced a series of high-profile executive appointments, signaling an aggressive strategy to not only expand its market share but also redefine how the value of artificial intelligence is measured in healthcare. The company has named seasoned industry leader Mike Valli to the newly created dual role of Chief Revenue Officer (CRO) and Chief Value Officer (CVO), a move that underscores a deliberate shift toward ensuring demonstrable financial and clinical outcomes for its health system partners.
This strategic hire is part of a broader expansion of the company's leadership team, which also includes the addition of Dr. Richa Gupta, former COO of Rush University Medical Center, as Vice President of Care Transformation, and Jeffrey Gerson, an early marketing leader from Instagram, as Vice President of Marketing. The appointments come as health systems nationwide grapple with unprecedented financial pressures, severe labor shortages, and epidemic levels of clinician burnout, creating a critical inflection point for technologies that can deliver tangible relief.
The Rise of the Chief Value Officer
The creation of a combined CRO and CVO role is a significant departure from traditional software sales models. By tasking a single executive with both driving revenue and guaranteeing customer value, Ambience is formalizing a commercial strategy that directly ties its own growth to the measurable success of its clients. Valli will be responsible for leading global go-to-market initiatives while simultaneously owning the framework that proves the platform's return on investment.
"Ambience is redefining how clinicians work and how health systems operate," Valli stated in the announcement. "This is one of the most important inflection points in healthcare—where AI moves from experimentation to mission-critical infrastructure. Ambience is uniquely positioned to lead that transformation."
This approach moves beyond theoretical benefits, aiming to deliver concrete improvements to a health system's operating margin. For every deployment, the goal is to build a clear ROI story that resonates with clinical, operational, and financial leaders. This focus on "value" is becoming increasingly critical as healthcare executives become more discerning about their technology investments, demanding solutions that solve core challenges rather than adding complexity.
Nikhil Buduma, CEO and Co-Founder of Ambience, emphasized this philosophy. "Healthcare AI will only scale if it creates real, system-level change," Buduma said. "Mike understands that value is not theoretical—it must be operational, financial, and clinical at the same time. His ability to bridge strategy, execution, and outcomes is rare, and he is exactly the leader we need as Ambience enters its next phase of growth."
A Powerhouse Team for Hypergrowth
The selection of Valli, with his deep industry pedigree, reinforces the seriousness of Ambience's ambitions. With over 15 years of experience, Valli has a proven track record of forging large-scale partnerships between technology firms and health systems. Most recently as Chief Commercial Officer at symplr, he led commercial strategy for a complex enterprise software portfolio. Prior to that, he spent over a decade in senior executive roles at Optum, where he was directly accountable for revenue growth and P&L performance while building some of the company’s largest health system partnerships. His consistent recognition by publications like Modern Healthcare and Business Insider as a transformative leader further validates his standing in the industry.
The strategic build-out of the executive team extends beyond Valli. The appointment of Dr. Richa Gupta as VP of Care Transformation brings profound operational and clinical expertise directly into the company's core. As the former Chief Operating Officer at Rush University Medical Center, Dr. Gupta led initiatives that drove double-digit volume growth and oversaw the hospital's nationally recognized COVID-19 response. Her role will focus on applying Ambience's AI to solve complex clinical and operational challenges, ensuring the technology is thoughtfully integrated into care delivery workflows to produce meaningful change.
Rounding out the new leadership is Jeffrey Gerson as VP of Marketing. Gerson's background is notably different, hailing from the world of high-growth consumer technology. As one of the earliest employees at Instagram, he founded the product marketing function and was instrumental in launching and scaling some of the platform's most successful global features. This expertise in building category-defining brands and communicating value at scale will be critical as Ambience seeks to penetrate a crowded and often skeptical healthcare market.
Tackling Healthcare's Core Crises
The timing of Ambience's strategic push aligns with a period of profound crisis for the U.S. healthcare system. Clinician burnout, driven largely by administrative burdens like documentation, has reached critical levels. Studies have consistently shown that physicians can spend up to two hours on EHR tasks for every one hour of direct patient care, contributing to high turnover rates and costing the industry billions annually. Ambience's platform directly targets this "pajama time" by automating clinical documentation at the point of care across more than 100 specialties.
Simultaneously, health systems are navigating razor-thin operating margins, squeezed by rising costs and complex reimbursement landscapes. Revenue leakage from inaccurate or incomplete documentation and coding errors can cost a single health system millions of dollars per year. By improving documentation quality and coding accuracy in real-time, the AI platform aims to protect and enhance revenue integrity, a crucial lifeline for financially strained organizations.
By focusing its technology on these intertwined issues—clinician experience, operational efficiency, and revenue integrity—Ambience is positioning itself not as a luxury or an experiment, but as essential infrastructure for the modern health system. The platform's ability to integrate directly with major EHRs like Epic and Oracle Cerner further reduces friction for adoption and ensures it can work within existing clinical workflows, a key factor for successful implementation at large, complex medical centers. With backing from top-tier investors including Oak HC/FT, Andreessen Horowitz (a16z), and the OpenAI Startup Fund, the company is well-capitalized to execute its ambitious vision for transforming healthcare administration.
